凯普生物：子公司六项呼吸道病原体核酸检测试剂盒获得医疗器械注册证

Core Viewpoint - The company announced that its wholly-owned subsidiary, Guangzhou Capbio Medical Technology Co., Ltd., has received the Medical Device Registration Certificate from the National Medical Products Administration for six respiratory pathogen nucleic acid detection kits [1] Group 1 - The detection kits utilize PCR-fluorescent probe method for in vitro qualitative detection of nucleic acids in throat swab samples [1] - The kits are designed to detect respiratory syncytial virus, influenza A virus, influenza B virus, adenovirus, parainfluenza virus, and Mycoplasma pneumoniae [1]